Trump’s FDA Cuts Are Putting Drug Development at Risk March 3, 2025 New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals.Please follow and like us: Related posts: Almost 30,000 suspected mpox cases in Africa this year, WHO says U.S. Secret Service failures before Trump rally shooting were ‘preventable,’ Senate panel finds Kanye West claims he and Bianca Censori “beat the Grammys” with naked dress stunt Disney+ to premiere new K-drama ‘Buried Hearts’, starring Park Hyung-sik Continue Reading Previous Previous post: DOJ Pushes For Immediate Trump Takeover Of Agency Flooded With Fired Worker Appeals Next Next post: Elon Musk’s $1 Spending Limit Is Paralyzing Federal Agencies Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Notify me of follow-up comments by email. Notify me of new posts by email. Δ Related News Dolly Parton’s husband, Carl Dean, dies aged 82 March 4, 2025 The revellers making Trinidad’s carnival more sustainable March 4, 2025
